🇺🇸 FDA
Patent

US 9527884

Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 9527884 (Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P9/10